GI
RXST icon

GAMMA Investing’s RxSight RXST Stock Holding History

GAMMA Investing’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$689 Sell
143
-1,131
-89% -$6.83K ﹤0.01% 3938
2026
Q1 		$7.85K Buy
1,274
+897
+238% +$7.45K ﹤0.01% 3190
2025
Q4 		$3.93K Buy
377
+157
+71% +$1.57K ﹤0.01% 3383
2025
Q3 		$1.98K Sell
220
-253
-53% -$2.22K ﹤0.01% 3452
2025
Q2 		$6.15K Buy
473
+136
+40% +$2.04K ﹤0.01% 3035
2025
Q1 		$8.51K Buy
337
+272
+418% +$8.08K ﹤0.01% 2828
2024
Q4 		$2.23K Sell
65
-60
-48% -$2.71K ﹤0.01% 3189
2024
Q3 		$6.18K Buy
125
+8
+7% +$410 ﹤0.01% 2666
2024
Q2 		$7.04K Buy
117
+40
+52% +$2.29K ﹤0.01% 2417
2024
Q1 		$3.97K Buy
77
+50
+185% +$2.45K ﹤0.01% 2509
2023
Q4 		$1.23K Buy
+27
New +$792 ﹤0.01% 2737

Other funds holding RXST

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.64B AUM 19.37% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

GAMMA Investing's RXST Position: Q2 2026 in Review

GAMMA Investing reduced its RxSight (RXST) stake by 89% in Q2 2026, selling an estimated $6.83K and leaving 143 shares worth $689. The position accounts for ﹤0.01% of the portfolio, ranked #3938.

GAMMA Investing first reported a position in RXST in Q4 2023 and has held it in 11 quarters since. The position peaked at $8.51K in Q1 2025. 7 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • GAMMA Investing held 143 shares of RxSight worth $689 as of Q2 2026.
  • GAMMA Investing sold 1,131 RxSight shares in Q2 2026, an estimated $6.83K.
  • RxSight made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3938 holding.
  • GAMMA Investing first reported a position in RxSight in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's RxSight position peaked at $8.51K in Q1 2025.
  • 7 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.